Aortyx
Aortyx is developing a minimally invasive solution for aortic dissection, a tear in the aortic wall. Their core product is a steerable catheter that deploys a bioresorbable patch to plug the tear, aiming to reduce the risks associated with current treatment options. The company's goal is to treat at least half of the cases with its first-generation product by reaching first-in-human testing within two years.
Funding Round: Series A
Funding Amount: €13.8M
Date: 12-Jun-2025
Investors: Ship2B Ventures, Clave Capital, Nara Capital, the EIC fund, the CDTI, angel investors, and a key corporate player in the aortic space
Markets: Healthtech, Medical Devices
HQ: Barcelona, Spain
Founded: 2017
Website: https://aortyx.com/
LinkedIn: https://www.linkedin.com/company/aortyx/
Crunchbase: https://www.crunchbase.com/organization/aortyx
Leave a Comment
Comments
No comments yet.